Read more at The Wall Street Journal.
FTC Accuses Drug Middlemen of Inflating Insulin Prices
Date: |
-
The Wall Street Journal - Business
FTC Accuses Drug Middlemen of Inflating Insulin Prices
The Federal Trade Commission sued the drug middlemen that health plans use to keep a lid on drug spending, accusing the firms of inflating the price of insulin.3 days ago -
The New York Times - Health
F.T.C. Accuses Drug Middlemen of Inflating Insulin Prices
The case takes aim at the major pharmacy benefit managers, agency officials said, claiming that they favored more expensive insulin products and forced patients to pay more.3 days ago -
CNBC - Business
FTC sues drug middlemen for allegedly inflating insulin prices
The FTC suit targets the three biggest so-called pharmacy benefit managers, UnitedHealth Group's Optum Rx, CVS Health's Caremark and Cigna's Express Scripts.2 days ago -
The Hill - Politics
FTC sues three largest drug middlemen for allegedly inflating insulin prices
The Federal Trade Commission (FTC) on Friday sued the three largest pharmacy benefit managers (PBMs) for engaging in alleged anticompetitive practices that boosted profits while “artificially” ...2 days ago -
NBC News - Top stories
Federal Trade Commission accuses three drug middlemen of inflating insulin prices
The Federal Trade Commission said Friday that it is suing three drug middlemen, accusing them of inflating insulin prices.2 days ago -
MarketWatch - Business
FTC sues prescription-drug middlemen over insulin prices, says drugmakers are also ‘on notice’
Pharmacy-benefit managers owned by CVS, Cigna and UnitedHealth “artificially inflated” prices for lifesaving medications, regulator alleges.3 days ago -
CBS News - Top stories
Drug middlemen illegally drive up the cost of insulin, FTC says
Regulators say the nation's largest pharmacy benefit managers are partly to blame for the soaring cost of insulin in the U.S.2 days ago -
Financial Times - Business
US drug ‘gatekeepers’ face FTC antitrust lawsuit over insulin prices
Complaint alleges pharmacy benefit managers owned by CVS, Cigna and UnitedHealth are keeping prices high3 days ago -
The Wall Street Journal - Business
The Price War in Weight-Loss Drugs Is Here
Novo Nordisk and Eli Lilly are offering discounts to encourage more insurance coverage of the medicines, which carry price tags of over $1,000 a month.3 days ago
More from The Wall Street Journal
-
The Wall Street Journal - Business
FTC Accuses Drug Middlemen of Inflating Insulin Prices
The Federal Trade Commission sued the drug middlemen that health plans use to keep a lid on drug spending, accusing the firms of inflating the price of insulin.3 days ago -
The Wall Street Journal - Business
Salesforce Taps Nvidia to Develop AI-Powered Avatars
The San Francisco companies said the collaboration will develop autonomous-agent and interactive-avatar experiences.5 days ago -
The Wall Street Journal - Business
Boeing Machinist Strike Adds Cash Crunch to New CEO's Rescue Mission
Ratings firms are warning that a prolonged work stoppage could sink the jet maker’s debt into junk status.September 15 -
The Wall Street Journal - Business
Battery Maker Northvolt to Cut Jobs Amid Cooling EV Market
Northvolt will cut jobs as part of a broad cost-saving plan to streamline the business following a period of aggressive expansion and as the global electric-vehicle market cools.September 9 -
The Wall Street Journal - Business
Verizon Strikes Deal to Acquire Frontier Communications
Verizon has agreed to acquire Frontier Communications in a $9.6 billion all-cash deal that would bolster the company’s fiber network to compete with rivals including AT&T.September 5